NM23-H1 GENE-EXPRESSION IN OVARIAN-TUMORS - A POTENTIAL TUMOR-MARKER

Citation
S. Kapitanovic et al., NM23-H1 GENE-EXPRESSION IN OVARIAN-TUMORS - A POTENTIAL TUMOR-MARKER, Anticancer research, 15(2), 1995, pp. 587-590
Citations number
19
Categorie Soggetti
Oncology
Journal title
ISSN journal
02507005
Volume
15
Issue
2
Year of publication
1995
Pages
587 - 590
Database
ISI
SICI code
0250-7005(1995)15:2<587:NGIO-A>2.0.ZU;2-#
Abstract
Ovarian carcinomas that have a distinctive natural history with early dissemination are particularly problematic. The aim of this immunohist ochemical study was to assess whether the nm23H1 gene product, which i n some tumors shows inverse association with metastatic potential, cou ld serve as a prognostic makrer for ovarian carcinomas. The study, bas ed on 73 benign and 54 malignant ovarian tumors, showed clear differen ces in the frequency of nm23-H1-positive samples, the intensity of sta ining and the histological localization of this protein. Differences w ere observed between normal ovary samples and benign lesions as well a s between benign tumors and ovarian carcinomas and were highly signifi cant. Furthermore, carcinomas that had detectable metastasis at the ti me of surgery were negative for nm23-H1 protein more frequently than t hose that did not. Although this is a prospective study in which colle ction of clinical data is ongoing, the results strongly suggest that n m23-H1 may serve as a potentially valuable marker for ovarian tumors.